Fig. 4: Potential predictors of response for immunotherapy in IM subtype of TNBC.

a TOP2A mutation in PR and non-PR patients of arm C. b Relationship between TOP2A mutation and tumor remission rate of arm C. c The change of amino acid positions related to TOP2A mutations in non-PR patients of arm C.